In vitro activity of imipenem/relebactam against Enterobacterales isolates from China: results from the Study of Monitoring Antimicrobial Resistance Trends (SMART), 2020-2022.
- DOI
- 10.1016/j.jgar.2026.10.005
- Published
- 2026 Oct 28
- Container
- Journal of global antimicrobial resistance
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jgar.2026.10.005,
title = {In vitro activity of imipenem/relebactam against Enterobacterales isolates from China: results from the Study of Monitoring Antimicrobial Resistance Trends (SMART), 2020-2022.},
author = {Chen Y and Fu Y and Wang Y and Jiang Y and Sun Y and Yu Y},
year = {2026},
journal = {Journal of global antimicrobial resistance},
doi = {10.1016/j.jgar.2026.10.005},
url = {https://doi.org/10.1016/j.jgar.2026.10.005}
}RIS
TY - JOUR TI - In vitro activity of imipenem/relebactam against Enterobacterales isolates from China: results from the Study of Monitoring Antimicrobial Resistance Trends (SMART), 2020-2022. AU - Chen Y AU - Fu Y AU - Wang Y AU - Jiang Y AU - Sun Y AU - Yu Y PY - 2026 JO - Journal of global antimicrobial resistance DO - 10.1016/j.jgar.2026.10.005 UR - https://doi.org/10.1016/j.jgar.2026.10.005 ER -
APA
Y, C., Y, F., Y, W., Y, J., Y, S., & Y, Y. (2026). In vitro activity of imipenem/relebactam against Enterobacterales isolates from China: results from the Study of Monitoring Antimicrobial Resistance Trends (SMART), 2020-2022.. Journal of global antimicrobial resistance. https://doi.org/10.1016/j.jgar.2026.10.005
Source records
- pubmed · retrieved 2026-11-10T19:51:10.608Z